Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes

John M Lachin1, Ionut Bebu2, Richard M Bergenstal3

  • 1The Biostatistics Center, The George Washington University, Rockville, MD jml@bsc.gwu.edu.

Diabetes Care
|April 14, 2017
PubMed

Insights

Glycemic variability within a day did not significantly impact microvascular complications in type 1 diabetes. Mean blood glucose levels were the primary factor influencing these diabetes complications.

Area of Science:

  • Endocrinology
  • Diabetology
  • Clinical Research

Background:

  • The Diabetes Control and Complications Trial (DCCT) established that intensive therapy reduces microvascular complications in type 1 diabetes.
  • These benefits were largely attributed to improved HbA1c levels, which correlate with complication risk.

Purpose of the Study:

  • To investigate the association between glucose variability and the development/progression of retinopathy, nephropathy, and cardiovascular autonomic neuropathy.
  • To determine if within-day and between-day glucose fluctuations impact microvascular complications independently of mean glucose levels.

Main Methods:

  • Analysis of quarterly 7-point glucose profiles from the DCCT.
  • Utilized measures of glucose variability including SD, MAGE, and M-value.
  • Employed Cox proportional hazards and longitudinal logistic regression models, adjusting for mean blood glucose.

Main Results:

  • No significant association was found between within-day glycemic variability and any microvascular complication when adjusted for mean blood glucose.
  • Only the longitudinal mean M-value showed a significant association with microalbuminuria after adjustment and correction for multiple testing.

Conclusions:

  • Within-day glucose variability, assessed from quarterly profiles, does not appear to be an independent risk factor for microvascular complications in type 1 diabetes.
  • Mean glucose level remains the dominant factor influencing the development of these complications.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...